ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,088,690 | -12.5% | 105,951 | -30.7% | 0.12% | -8.5% |
| Q2 2023 | $59,549,185 | -52.5% | 152,796 | -54.6% | 0.13% | -54.1% |
| Q1 2023 | $125,334,422 | +15.1% | 336,396 | +17.0% | 0.28% | +8.1% |
| Q4 2022 | $108,874,227 | +957.8% | 287,396 | +721.1% | 0.26% | +1081.8% |
| Q4 2020 | $10,293,000 | +56.8% | 35,000 | +40.0% | 0.02% | +37.5% |
| Q3 2020 | $6,563,000 | -91.5% | 25,000 | -97.5% | 0.02% | -90.7% |
| Q3 2018 | $77,052,000 | -38.2% | 1,015,981 | -32.5% | 0.17% | -39.9% |
| Q2 2018 | $124,704,000 | +63.3% | 1,505,000 | +58.5% | 0.29% | +60.7% |
| Q1 2018 | $76,378,000 | +60.2% | 949,500 | +25.8% | 0.18% | +64.8% |
| Q4 2017 | $47,671,000 | +1305.4% | 755,000 | +403.3% | 0.11% | +1250.0% |
| Q3 2017 | $3,392,000 | +6.6% | 150,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $3,182,000 | – | 150,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |